| review article | Q7318358 |
| scholarly article | Q13442814 |
| P356 | DOI | 10.1007/S00401-008-0366-2 |
| P698 | PubMed publication ID | 18369648 |
| P50 | author | Dietmar R. Thal | Q43145446 |
| P2093 | author name string | W Sue T Griffin | |
| Estifanos Ghebremedhin | |||
| Rob A I de Vos | |||
| P2860 | cites work | Familial meningocerebrovascular amyloidosis, Hungarian type, with mutant transthyretin (TTR Asp18Gly) | Q48851621 |
| A stop-codon mutation in the BRI gene associated with familial British dementia | Q22010197 | ||
| Cerebral amyloid angiopathy: amyloid beta accumulates in putative interstitial fluid drainage pathways in Alzheimer's disease | Q24682442 | ||
| Structural and functional disruption of vascular smooth muscle cells in a transgenic mouse model of amyloid angiopathy | Q28359737 | ||
| Cerebral amyloid angiopathies: a pathologic, biochemical, and genetic view | Q34268430 | ||
| Amyloid angiopathy and variability in amyloid beta deposition is determined by mutation position in presenilin-1-linked Alzheimer's disease | Q35842271 | ||
| Sequence of Abeta-protein deposition in the human medial temporal lobe. | Q42492271 | ||
| Familial Danish dementia: a novel form of cerebral amyloidosis associated with deposition of both amyloid-Dan and amyloid-beta | Q43918003 | ||
| Cerebral amyloid angiopathy: incidence and complications in the aging brain. II. The distribution of amyloid vascular changes | Q46640803 | ||
| Cerebral infarction in Alzheimer's disease is associated with severe amyloid angiopathy and hypertension | Q46709828 | ||
| Vascular pathology in Alzheimer disease: correlation of cerebral amyloid angiopathy and arteriosclerosis/lipohyalinosis with cognitive decline | Q47300836 | ||
| Distribution of Alzheimer-type pathologic changes in nondemented elderly individuals matches the pattern in Alzheimer's disease | Q48442778 | ||
| Phases of A beta-deposition in the human brain and its relevance for the development of AD. | Q48567985 | ||
| Two types of sporadic cerebral amyloid angiopathy. | Q48661743 | ||
| Diagnosis of cerebral amyloid angiopathy. Sensitivity and specificity of cortical biopsy | Q48670233 | ||
| P433 | issue | 6 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | Alzheimer's disease | Q11081 |
| cerebral amyloid angiopathy | Q191562 | ||
| P304 | page(s) | 599-609 | |
| P577 | publication date | 2008-03-28 | |
| P1433 | published in | Acta Neuropathologica | Q343168 |
| P1476 | title | Cerebral amyloid angiopathy and its relationship to Alzheimer's disease | |
| P478 | volume | 115 |
| Q92105199 | 3D Reconstruction of the Neurovascular Unit Reveals Differential Loss of Cholinergic Innervation in the Cortex and Hippocampus of the Adult Mouse Brain |
| Q30579707 | A novel Aβ-fibrinogen interaction inhibitor rescues altered thrombosis and cognitive decline in Alzheimer's disease mice |
| Q37615879 | APOE Genotype Differentially Modulates Effects of Anti-Aβ, Passive Immunization in APP Transgenic Mice |
| Q34153400 | Ablation of MMP9 gene ameliorates paracellular permeability and fibrinogen-amyloid beta complex formation during hyperhomocysteinemia. |
| Q57259399 | Abstracts |
| Q58581176 | AlF-NODA Benzothiazole Derivatives as Imaging Agents for Cerebrovascular Amyloid in Cerebral Amyloid Angiopathy |
| Q38818321 | Altered Sphingolipid Balance in Capillary Cerebral Amyloid Angiopathy. |
| Q45927193 | Alzheimer's disease pathology in the neocortex and hippocampus of the western lowland gorilla (Gorilla gorilla gorilla). |
| Q34411401 | Alzheimer's disease peptide beta-amyloid interacts with fibrinogen and induces its oligomerization. |
| Q38066233 | Alzheimer’s disease, cerebrovascular disease, and the β-amyloid cascade. |
| Q42914740 | Amyloid-beta-induced occludin down-regulation and increased permeability in human brain endothelial cells is mediated by MAPK activation. |
| Q30828708 | An autopsy-confirmed case of progressive supranuclear palsy with predominant postural instability. |
| Q92106898 | Anti-Aβ Antibodies and Cerebral Amyloid Angiopathy Complications |
| Q36723965 | Antibodies against small heat-shock proteins in Alzheimer's disease as a part of natural human immune repertoire or activation of humoral response? |
| Q48818993 | Association of Plasma Aβ40 Peptides, But Not Aβ42, with Coronary Artery Disease and Diabetes Mellitus |
| Q90713456 | Astrocytic changes with aging and Alzheimer's disease-type pathology in chimpanzees |
| Q89200433 | Autotaxin⁻Lysophosphatidic Acid Signaling in Alzheimer's Disease |
| Q90609201 | Biomarkers in Alzheimer's disease: Evaluation of platelets, hemoglobin and vitamin B12 |
| Q27318080 | Blood platelets in the progression of Alzheimer's disease |
| Q27024202 | CD4 T cells in immunity and immunotherapy of Alzheimer's disease |
| Q37409402 | Can Creutzfeldt-Jakob disease unravel the mysteries of Alzheimer? |
| Q41542097 | Can brain impermeable BACE1 inhibitors serve as anti-CAA medicine? |
| Q99585321 | Can post-mortem MRI be used as a proxy for in vivo? A case study |
| Q50435914 | Capillary amyloid-β protein deposition in a population-based study (Vantaa 85+). |
| Q36037652 | Cerebral amyloid angiopathy and its co-occurrence with Alzheimer's disease and other cerebrovascular neuropathologic changes |
| Q48143369 | Cerebral amyloid angiopathy as a cause of neurodegeneration |
| Q37613107 | Cerebral amyloid angiopathy in the aetiology and immunotherapy of Alzheimer disease |
| Q35767208 | Cerebral hypoperfusion accelerates cerebral amyloid angiopathy and promotes cortical microinfarcts |
| Q44355626 | Characterization of ApoJ-reconstituted high-density lipoprotein (rHDL) nanodisc for the potential treatment of cerebral β-amyloidosis. |
| Q48226352 | Characterization of Cerebral Damage in a Monkey Model of Alzheimer's Disease Induced by Intracerebroventricular Injection of Streptozotocin |
| Q36566738 | Choroidal Thickness in Patients with Mild Cognitive Impairment and Alzheimer's Type Dementia |
| Q26801541 | Clearance systems in the brain-implications for Alzheimer disease |
| Q35687048 | Consequences of Aberrant Insulin Regulation in the Brain: Can Treating Diabetes be Effective for Alzheimer's Disease |
| Q64085110 | Decreased CSF Levels of ß-Amyloid in Patients With Cortical Superficial Siderosis |
| Q92801314 | Deficiency of tPA Exacerbates White Matter Damage, Neuroinflammation, Glymphatic Dysfunction and Cognitive Dysfunction in Aging Mice |
| Q64257598 | Development of a Multicomponent Intervention to Prevent Alzheimer's Disease |
| Q91670427 | Down syndrome, Alzheimer disease, and cerebral amyloid angiopathy: The complex triangle of brain amyloidosis |
| Q38260539 | Drug access to the central nervous system in Alzheimer's disease: preclinical and clinical insights. |
| Q36896989 | Dura mater is a potential source of Aβ seeds |
| Q33793048 | Early-onset formation of parenchymal plaque amyloid abrogates cerebral microvascular amyloid accumulation in transgenic mice |
| Q90739055 | Emerging links between cerebrovascular and neurodegenerative diseases-a special role for pericytes |
| Q38032520 | Fibrinogen and altered hemostasis in Alzheimer's disease |
| Q30495250 | Fibrinogen and beta-amyloid association alters thrombosis and fibrinolysis: a possible contributing factor to Alzheimer's disease |
| Q33747695 | Genetics and molecular pathogenesis of sporadic and hereditary cerebral amyloid angiopathies |
| Q38906535 | HIV-1 Tat-induced cerebrovascular toxicity is enhanced in mice with amyloid deposits |
| Q26852526 | Heart failure and Alzheimer's disease |
| Q39755348 | Heparan sulfate mediates amyloid-beta internalization and cytotoxicity |
| Q34209319 | High-definition characterization of cerebral β-amyloid angiopathy in Alzheimer's disease |
| Q37104293 | Hyperhomocysteinemia exacerbates Alzheimer's disease pathology by way of the β-amyloid fibrinogen interaction |
| Q39041998 | Hypoxia/ischemia activate processing of Amyloid Precursor Protein: impact of vascular dysfunction in the pathogenesis of Alzheimer's disease |
| Q47223724 | Iatrogenic Creutzfeldt-Jakob disease with Amyloid-β pathology: an international study |
| Q38198632 | Imaging of cerebrovascular pathology in animal models of Alzheimer's disease |
| Q96110132 | Impaired perfusion and capillary dysfunction in prodromal Alzheimer's disease |
| Q51366618 | In vivo detection of cortical microinfarcts on ultrahigh-field MRI. |
| Q27001177 | Interaction between therapeutic interventions for Alzheimer's disease and physiological Aβ clearance mechanisms |
| Q38365567 | Is Vasomotion in Cerebral Arteries Impaired in Alzheimer's Disease? |
| Q37724591 | Ischemic stroke in the elderly: an overview of evidence |
| Q39315645 | Kynurenines and other novel therapeutic strategies in the treatment of dementia |
| Q29976920 | LRP1 in brain vascular smooth muscle cells mediates local clearance of Alzheimer's amyloid-β. |
| Q93001087 | Lewy pathology in Parkinson's disease consists of crowded organelles and lipid membranes |
| Q34268223 | Linking cardiometabolic disorders to sporadic Alzheimer's disease: a perspective on potential mechanisms and mediators |
| Q85211709 | Low Avidity and Level of Serum Anti-Aβ Antibodies in Patients With Cerebral Amyloid Angiopathy-Related Cerebral Hemorrhage |
| Q30275974 | Lymphatics in Neurological Disorders: A Neuro-Lympho-Vascular Component of Multiple Sclerosis and Alzheimer's Disease? |
| Q90224665 | Modified amyloid variants in pathological subgroups of β-amyloidosis |
| Q26768648 | Molecular Pathological Classification of Neurodegenerative Diseases: Turning towards Precision Medicine |
| Q38809649 | Monoaminergic neuropathology in Alzheimer's disease |
| Q34635272 | National Institute on Aging-Alzheimer's Association guidelines for the neuropathologic assessment of Alzheimer's disease |
| Q35706615 | National Institute on Aging-Alzheimer's Association guidelines for the neuropathologic assessment of Alzheimer's disease: a practical approach |
| Q42696477 | Neuro-Coagulopathy: Blood Coagulation Factors in Central Nervous System Diseases |
| Q59808647 | Neuro-Immune Hemostasis: Homeostasis and Diseases in the Central Nervous System |
| Q39355193 | Neurocognitive Effect of Nootropic Drug Brahmi (Bacopa monnieri) in Alzheimer's Disease |
| Q57306341 | Neuropathology of Alzheimer's Disease and its Variants |
| Q33647172 | Neurovascular changes measured by time-of-flight MR angiography in cholesterol-fed rabbits with cortical amyloid beta-peptide accumulation. |
| Q33782706 | Neurovascular mechanisms and blood-brain barrier disorder in Alzheimer's disease |
| Q46434933 | Non-inflammatory cerebral amyloid angiopathy as a cause of rapidly progressive dementia: A case study |
| Q44020364 | Noninvasive magnetic resonance imaging detection of cerebral amyloid angiopathy-related microvascular alterations using superparamagnetic iron oxide particles in APP transgenic mouse models of Alzheimer's disease: application to passive Abeta immuno |
| Q90194375 | Norvaline Restores the BBB Integrity in a Mouse Model of Alzheimer's Disease |
| Q35862439 | Parenchymal and vascular Abeta-deposition and its effects on the degeneration of neurons and cognition in Alzheimer's disease. |
| Q36754568 | Pathology and pathogenesis of vascular cognitive impairment-a critical update |
| Q48715103 | Platelets contribute to amyloid-β aggregation in cerebral vessels through integrin αIIbβ3-induced outside-in signaling and clusterin release |
| Q57811376 | Platelets isolated from an Alzheimer mouse damage healthy cortical vessels and cause inflammation in an organotypic ex vivo brain slice model |
| Q30814231 | Possible modification of Alzheimer's disease by statins in midlife: interactions with genetic and non-genetic risk factors |
| Q35946138 | Prion-like spread of protein aggregates in neurodegeneration |
| Q55266481 | Proteomics analysis identifies new markers associated with capillary cerebral amyloid angiopathy in Alzheimer's disease. |
| Q36237665 | Quercetin protects human brain microvascular endothelial cells from fibrillar β-amyloid1-40-induced toxicity |
| Q38034108 | Quintessential risk factors: their role in promoting cognitive dysfunction and Alzheimer's disease |
| Q48432787 | Reduced nitric oxide bioavailability mediates cerebroarterial dysfunction independent of cerebral amyloid angiopathy in a mouse model of Alzheimer's disease. |
| Q55659163 | Retinal oxygen metabolism in patients with mild cognitive impairment. |
| Q37800132 | Review: sporadic cerebral amyloid angiopathy |
| Q60910185 | Serum levels of proteins involved in amyloid-β clearance are related to cognitive decline and neuroimaging changes in mild cognitive impairment |
| Q48887540 | Stages of granulovacuolar degeneration: their relation to Alzheimer's disease and chronic stress response |
| Q34981226 | Stress, exercise, and Alzheimer's disease: a neurovascular pathway |
| Q42746027 | Superficial siderosis in cerebral amyloid angiopathy |
| Q48640345 | Tau pathology in Creutzfeldt-Jakob disease revisited |
| Q98564460 | Tau reduction in aged mice does not impact Microangiopathy |
| Q36335013 | Taxifolin inhibits amyloid-β oligomer formation and fully restores vascular integrity and memory in cerebral amyloid angiopathy |
| Q37211285 | The association between small vessel infarcts and the activities of amyloid-β peptide degrading proteases in apolipoprotein E4 allele carriers. |
| Q41076513 | The blood clotting Factor XIIIa forms unique complexes with amyloid-beta (Aβ) and colocalizes with deposited Aβ in cerebral amyloid angiopathy |
| Q33936586 | The blood-brain barrier and microvascular water exchange in Alzheimer's disease. |
| Q90203836 | The effects of cerebral amyloid angiopathy on integrity of the blood-brain barrier |
| Q30477118 | The influence of chronic cerebral hypoperfusion on cognitive function and amyloid β metabolism in APP overexpressing mice |
| Q34484708 | The overlap between vascular disease and Alzheimer's disease--lessons from pathology |
| Q39247056 | The seeds of neurodegeneration: prion-like spreading in ALS |
| Q38094984 | The senescence hypothesis of disease progression in Alzheimer disease: an integrated matrix of disease pathways for FAD and SAD. |
| Q46046285 | Vascular dementia: Current concepts and nomenclature harmonization |
| Q34282041 | Vascular dementia: different forms of vessel disorders contribute to the development of dementia in the elderly brain |
| Q33699436 | Vascular pathology in the aged human brain |
| Q35200750 | Vascular β-amyloid and early astrocyte alterations impair cerebrovascular function and cerebral metabolism in transgenic arcAβ mice |
| Q26781557 | Vasculoprotection as a Convergent, Multi-Targeted Mechanism of Anti-AD Therapeutics and Interventions |
| Q43520942 | β-Amyloid context intensifies vascular smooth muscle cells induced inflammatory response and de-differentiation. |
Search more.